Please assess the completion status of the following clinical trial:

Trial Title: Cerebral Autoregulation Monitoring During Cardiac Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female patients undergoing primary or re-operative Coronary Artery Bypass Graft (CABG) and/or valvular surgery or ascending aorta surgery that requires Cardio-pulmonary bypass (CPB) who are at high risk for neurologic complications (stroke or encephalopathy) as determined by a Johns Hopkins risk score of \>0.02~Exclusion Criteria:~* Contraindication to MRI imaging (e.g., permanent pacemaker, cerebral arterial vascular clips)~* Liver function test before surgery more than twice the upper limit of institutional normal~* Pre-existing renal dysfunction defined as an estimated glomerular filtration rate of ≤60 mL/min, or current renal dialysis~* Emergency surgery~* Inability to attend outpatient visits~* Visual impairment or inability to speak and read English. The patient will be excluded from further study if an adequate temporal window for Transcranial Doppler (TCD) monitoring can not be identified before surgery.

- Gender: ALL
- Minimum Age: 55 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control (Type: ACTIVE_COMPARATOR): Blood pressure targets during cardiopulmonary bypass based on institutional standards of empiric management.
- Intervention (Type: EXPERIMENTAL): Blood pressure management based on cerebral autoregulation data.

Based on this trial design, predict the completion outcome and termination type (if applicable).